Loading clinical trials...
Loading clinical trials...
The primary purpose of this study is to evaluate the safety and efficacy of lubiprostone in a pediatric population with constipation, including the pharmacokinetics of lubiprostone, in a subset of pat...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Sucampo Pharma Americas, LLC
Collaborators
NCT07545772 · Irritable Bowel Syndrome, Constipation
NCT05588323 · Opioid-Induced Constipation (OIC)
NCT07215351 · Constipation, Bloating
NCT07202481 · Constipation - Functional
NCT07462481 · Constipation
Phoenix Children's Hospital
Phoenix, Arizona
Arkansas Pediatric Clinic
Little Rock, Arkansas
Children's Hospital and Research Center Oakland
Oakland, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions